JP2009524692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009524692A5 JP2009524692A5 JP2008552581A JP2008552581A JP2009524692A5 JP 2009524692 A5 JP2009524692 A5 JP 2009524692A5 JP 2008552581 A JP2008552581 A JP 2008552581A JP 2008552581 A JP2008552581 A JP 2008552581A JP 2009524692 A5 JP2009524692 A5 JP 2009524692A5
- Authority
- JP
- Japan
- Prior art keywords
- registered trademark
- ophthalmic formulation
- subject
- tears
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76194506P | 2006-01-25 | 2006-01-25 | |
| PCT/US2007/061065 WO2007087609A2 (en) | 2006-01-25 | 2007-01-25 | Formulations and methods for treating dry eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009524692A JP2009524692A (ja) | 2009-07-02 |
| JP2009524692A5 true JP2009524692A5 (https=) | 2011-03-17 |
Family
ID=38309951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552581A Pending JP2009524692A (ja) | 2006-01-25 | 2007-01-25 | ドライアイのための処方物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070254841A1 (https=) |
| EP (1) | EP1981491A4 (https=) |
| JP (1) | JP2009524692A (https=) |
| AU (1) | AU2007208054A1 (https=) |
| CA (1) | CA2636646A1 (https=) |
| WO (1) | WO2007087609A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1654002B2 (en) | 2003-08-07 | 2014-01-29 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes |
| US8372814B2 (en) * | 2004-06-07 | 2013-02-12 | Ista Pharmaceuticals, Inc. | Ophthalmic formulations and uses thereof |
| US8748402B2 (en) | 2004-06-07 | 2014-06-10 | Bausch & Lomb Pharma Holdings Corp. | Ophthalmic formulations and uses thereof |
| US8137111B2 (en) * | 2007-06-28 | 2012-03-20 | Eye Care And Cure Pte. Ltd | Model human eye |
| AU2009202969B1 (en) * | 2009-07-23 | 2009-11-19 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| US7842714B2 (en) * | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
| US9192571B2 (en) * | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| US8778999B2 (en) * | 2009-03-05 | 2014-07-15 | Insite Vision Incorporated | Non-steroidal anti-inflammatory ophthalmic compositions |
| PH12012501111A1 (en) | 2009-12-03 | 2016-09-09 | Novartis Ag | Carboxyvinyl polymer-containing nanoparticles suspensions |
| AU2011237646A1 (en) * | 2010-04-09 | 2012-11-08 | Allergan, Inc. | Ketorolac compositions for corneal wound healing |
| US8684743B2 (en) | 2010-07-23 | 2014-04-01 | Eye Care And Cure Pte. Ltd | Model human eye and face manikin for use therewith |
| CN102557976B (zh) * | 2010-12-15 | 2015-06-10 | 辽宁盛京制药有限公司 | 溴芬酸有机盐及其制备方法、其组合物及用途 |
| WO2012136969A2 (en) * | 2011-04-05 | 2012-10-11 | Anant Sharma | Ophthalmic treatments |
| US20130023575A1 (en) * | 2011-07-22 | 2013-01-24 | Kamran Hosseini | Compositions and methods for the treatment of ocular surface allergies |
| WO2014207769A1 (en) | 2013-06-27 | 2014-12-31 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
| ES2837626T3 (es) | 2013-07-10 | 2021-07-01 | Matrix Biology Inst | Composiciones de hialuronano con alta elasticidad y usos de las mismas |
| TWI670057B (zh) * | 2013-12-25 | 2019-09-01 | 日商日本股份有限公司Ｌｔｔ生物醫藥 | 治療乾眼用滴眼劑 |
| US9775861B1 (en) * | 2014-09-26 | 2017-10-03 | Paul S. Jensen | Dry eye composition and method for preparing the composition |
| ES2871199T3 (es) | 2015-09-24 | 2021-10-28 | Matrix Biology Inst | Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas |
| WO2023280319A1 (zh) * | 2021-07-09 | 2023-01-12 | 广州润尔眼科生物科技有限公司 | 洛索洛芬钠在制备治疗干眼的药物中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230724A (en) * | 1979-07-16 | 1980-10-28 | Allergan Pharmaceuticals, Inc. | Method of treating vascularization of the eye with Flurbiprofen |
| US4407791A (en) * | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
| DE3612537C1 (de) * | 1986-04-14 | 1987-07-16 | Dispersa Ag | Arzneimittel zur Behandlung von Entzuendungen im Auge |
| US5110493A (en) * | 1987-09-11 | 1992-05-05 | Syntex (U.S.A.) Inc. | Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant |
| US4910225A (en) * | 1988-01-27 | 1990-03-20 | Senju Pharmaceutical Co., Ltd. | Locally administrable therapeutic composition for inflammatory disease |
| US4960799A (en) * | 1988-09-13 | 1990-10-02 | Ciba-Geigy Corporation | Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use |
| US5563972A (en) * | 1992-11-27 | 1996-10-08 | Siemens Aktiengesellschaft | Radio frequency shielding arrangement for a plug which has a light guide and can be connected to a module frame |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| DE69839355T2 (de) * | 1997-07-29 | 2009-06-04 | Alcon Laboratories, Inc., Fort Worth | Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat |
| US6552020B1 (en) * | 1999-07-30 | 2003-04-22 | Allergan, Inc. | Compositions including antibiotics and methods for using same |
| MXPA04008171A (es) * | 2002-02-22 | 2004-11-26 | Pharmacia Corp | Formulacion oftalmica con sistema de goma. |
| US6828356B2 (en) * | 2002-07-29 | 2004-12-07 | Ast Products, Inc. | Preparation of ophthalmic compositions |
| US6806364B2 (en) * | 2002-07-29 | 2004-10-19 | Ast Products, Inc. | Ophthalmic compositions |
| PT1586316E (pt) * | 2003-01-21 | 2008-05-28 | Senju Pharma Co | Preparação líquida aquosa contendo ácido 2-amino-3-(4- bromobenzoil)fenilacético |
| US20050239745A1 (en) * | 2004-03-03 | 2005-10-27 | Ophthalmic Research Associates, Inc. | Novel topical ophthalmic formulations |
| WO2005101982A2 (en) * | 2004-03-24 | 2005-11-03 | Sun Pharmaceutical Industries Limited | A stable ophthalmic composition |
| BRPI0609227A2 (pt) * | 2005-05-10 | 2010-03-09 | Alcon Inc | composições de suspensão de nepafenac e outros fármacos oftálmicos, bem como uso das referidas composições no tratamento tópico de distúrbios oftálmicos |
-
2007
- 2007-01-25 US US11/698,778 patent/US20070254841A1/en not_active Abandoned
- 2007-01-25 CA CA002636646A patent/CA2636646A1/en not_active Abandoned
- 2007-01-25 AU AU2007208054A patent/AU2007208054A1/en not_active Abandoned
- 2007-01-25 EP EP07717416A patent/EP1981491A4/en not_active Withdrawn
- 2007-01-25 JP JP2008552581A patent/JP2009524692A/ja active Pending
- 2007-01-25 WO PCT/US2007/061065 patent/WO2007087609A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009524692A5 (https=) | ||
| ES2606041T3 (es) | Composición de baja dosis de topiramato/fentermina y métodos de uso de la misma | |
| JP5140757B2 (ja) | 薬物徐放性ハイドロゲルコンタクトレンズ及び薬物徐放性ハイドロゲルコンタクトレンズを用いた薬物放出方法 | |
| TW200400055A (en) | Ophthalmic formulation with novel gum composition | |
| JP2024107166A (ja) | ドライアイ疾患を処置するための製剤 | |
| US20070297981A1 (en) | Formulations and methods for treating dry eye | |
| ES2301795T3 (es) | Forma de administracion transepicutanea para el tratamiento del sindrome de las piernas inquietas. | |
| US20090010850A1 (en) | Formulations and methods for treating dry eye | |
| US20070254841A1 (en) | Formulations and methods for treating dry eye | |
| JP2018522070A (ja) | 白内障の処置用組成物 | |
| JP2010533225A5 (https=) | ||
| JP2022516945A5 (https=) | ||
| EP2437602A1 (en) | Ophthalmic formulations, methods of manufacture, and methods of using same | |
| MX2014003421A (es) | Composiciones y metodos para el tratamiento de presbicia, hipermetropia leve, y astigmatismo irregular. | |
| JP2011503061A (ja) | 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物 | |
| MX2008012496A (es) | Formulaciones de farmacos anti-inflamatorios no esteroidales de baja dosis y beta-ciclodextrina. | |
| AU2007243334A1 (en) | Compositions for the treatment and prevention of eyelid swelling | |
| US20080039398A1 (en) | Formulations and methods for treating dry eye | |
| JP2016520653A5 (https=) | ||
| SK11093A3 (en) | Treatment of disease employing hyaluronic and nsaids | |
| Joshi et al. | Thin films: a promising approach for drug delivery system | |
| US10391074B2 (en) | Topical preparation for pain relief | |
| Griffith et al. | Human platelet lysate delivered via an ocular wound chamber for the treatment of corneal epithelial injuries | |
| US8431613B2 (en) | Memory fixation accelerator | |
| WO2015157729A1 (en) | Pharmaceutical formulations an comprising analgesic agent, a nonsteroidal anti-inflammatory agent, a gastric acid production suppressant and an anti-nauseant |